Alcobra Ltd. to Release Third Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on November 17
November 05, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 5, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
FDA Grants Fast Track Designation to Alcobra's MDX for Fragile X Syndrome
September 21, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Second Quarter 2015 Financial Results and Provides Corporate Update
August 13, 2015 07:00 ET
|
Alcobra Ltd.
Conference Call & Webcast today at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
Alcobra Ltd. to Release Second Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on August 13
August 03, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 3, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Election of Dr. Joao Siffert to Board of Directors
July 13, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Isreal, July 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces Results From Phase 2 Clinical Trial of MDX for Fragile X Syndrome
June 24, 2015 06:00 ET
|
Alcobra Ltd.
Study Did Not Meet Primary Endpoint of Change on the ADHD RS-IV Inattentive Subscale
Statistically Significant Improvements Seen on Two Secondary Endpoints: the Vineland Adaptive Behavior Scale...
Alcobra Ltd. to Present Results of Phase II Fragile X Trial in a Conference Call & Webcast Presentation on Wednesday, June 24
June 23, 2015 16:01 ET
|
Alcobra Ltd.
TEL AVIV, Israel, June 23, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Two Conferences in June
May 28, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, May 28, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Announces First Quarter 2015 Financial Results and Provides Corporate Update
May 06, 2015 07:30 ET
|
Alcobra Ltd.
Alcobra Provides Update on Results of FDA Meeting
Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
TEL AVIV, Israel, May 6, 2015 (GLOBE NEWSWIRE) -- Alcobra...
Alcobra Ltd. to Participate at Two Conferences in May
April 27, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, April 27, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...